U.S. Brand Name
Truvada
Abbreviation(s)
FTC/TDF
First U.S. Approval
NRTI Based?
Yes
One Dose Daily?
Yes
Single Tablet Regimen
No
U.S. FDA Label
U.S. Manufacturer
Formulations
| Strength | Formulation | Image | Description | Boosted |
|---|---|---|---|---|
|
FTC 100 mg, TDF 150 mg
|
Film-Coated Tablets
|
|
Blue oval tablet debossed with "GSI" on one side and with "703" on the other,
|
No
|
|
FTC 200 mg, TDF 300 mg
|
Film-Coated Tablets
|
|
Blue capsule-shaped tablet with 701 imprint on one side and GILEAD on the other.
|
No
|
|
FTC 133 mg, TDF 200 mg
|
Film-Coated Tablets
|
|
Blue, oval/rectangular tablet with imprint of 704 on one side and GSI on the other.
|
No
|
|
FTC 167 mg, TDF 250 mg
|
Film-Coated Tablets
|
|
Blue, oval tablet with 705 imprinted on one side and GSI on the other.
|
No
|
Adult dosing
Pediatric dosing
References
Assistance Programs
